Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
34.87
+1.28 (3.81%)
At close: Apr 28, 2026, 4:00 PM EDT
34.69
-0.18 (-0.52%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $577.7 million as of April 28, 2026. Its market cap has increased by 1,105.56% in one year.
Market Cap
577.70M
Enterprise Value
466.69M
1-Year Change
1,105.56%
Ranking
Category
Stock Price
$34.87
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has increased from $346.92M to $577.70M, an increase of 66.52%. That is a compound annual growth rate of 6.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 556.49M | 464.57% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 581.94M |
| Prothena Corporation | 578.70M |
| Ocugen | 561.94M |
| Rigel Pharmaceuticals | 559.76M |
| Altimmune | 553.47M |
| Kyverna Therapeutics | 548.40M |
| AgomAb Therapeutics NV | 538.54M |
| Tectonic Therapeutic | 535.88M |